AMLX
AMLX
US03237H1014
Amylyx Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
3.53B EUR
2B EUR
1.54B EUR
1.33B EUR
Enterprise Value
2.79B EUR
1.96B EUR
1.32B EUR
1.11B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-24.37x
--
--
--
Price to Sales
--
--
--
--
Price to Book
13.1x
8.36x
5.65x
4.35x
EV/Revenue
--
--
--
--
EV/EBITDA
-17.22x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-2.19%
-6.34%
-7.81%
-6.3%
ende